MALLEO, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 14.748
NA - Nord America 11.785
AS - Asia 9.120
SA - Sud America 1.466
AF - Africa 217
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 37.373
Nazione #
US - Stati Uniti d'America 11.503
RU - Federazione Russa 6.159
SG - Singapore 3.774
CN - Cina 2.988
GB - Regno Unito 2.485
IT - Italia 1.701
BR - Brasile 1.205
DE - Germania 895
HK - Hong Kong 881
FR - Francia 857
IE - Irlanda 750
SE - Svezia 748
VN - Vietnam 606
FI - Finlandia 422
KR - Corea 197
NL - Olanda 155
CA - Canada 142
JP - Giappone 141
UA - Ucraina 132
IN - India 111
MX - Messico 111
AR - Argentina 110
PL - Polonia 78
ID - Indonesia 70
TR - Turchia 70
ES - Italia 65
AT - Austria 58
ZA - Sudafrica 55
BE - Belgio 53
BD - Bangladesh 50
IQ - Iraq 37
TG - Togo 37
EC - Ecuador 36
CZ - Repubblica Ceca 34
LT - Lituania 32
BJ - Benin 31
PK - Pakistan 28
CO - Colombia 24
MA - Marocco 24
VE - Venezuela 24
AU - Australia 22
PY - Paraguay 21
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 17
TN - Tunisia 16
CL - Cile 15
PE - Perù 15
JO - Giordania 14
CH - Svizzera 12
DZ - Algeria 12
IL - Israele 12
AZ - Azerbaigian 11
KE - Kenya 11
LV - Lettonia 11
GR - Grecia 10
IR - Iran 10
KG - Kirghizistan 10
NP - Nepal 10
RO - Romania 10
TH - Thailandia 10
DK - Danimarca 9
HU - Ungheria 9
KZ - Kazakistan 9
NO - Norvegia 9
BG - Bulgaria 8
EG - Egitto 8
AL - Albania 7
BO - Bolivia 6
NZ - Nuova Zelanda 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
JM - Giamaica 5
PH - Filippine 5
RS - Serbia 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
DO - Repubblica Dominicana 4
GA - Gabon 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
PT - Portogallo 4
UG - Uganda 4
UY - Uruguay 4
AM - Armenia 3
BB - Barbados 3
EE - Estonia 3
EU - Europa 3
GH - Ghana 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
NG - Nigeria 3
PA - Panama 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BW - Botswana 2
BY - Bielorussia 2
Totale 37.331
Città #
Moscow 2.171
Southend 2.152
Singapore 1.784
Dallas 1.773
Chandler 1.498
Ashburn 1.063
Hong Kong 871
Dublin 726
Beijing 564
Jacksonville 502
Woodbridge 493
Verona 446
Houston 360
New York 343
Ann Arbor 306
The Dalles 305
Munich 293
Los Angeles 248
Lawrence 243
Princeton 243
Jinan 215
Wilmington 215
Ho Chi Minh City 207
Nanjing 178
Helsinki 167
Shenyang 157
Boardman 142
Redondo Beach 141
Hanoi 132
São Paulo 132
Hebei 118
Tokyo 112
Redmond 111
Santa Clara 110
Buffalo 108
Columbus 96
Sindelfingen 96
Turku 94
Tianjin 90
Milan 83
Haikou 79
Seattle 79
London 74
Hangzhou 72
Ningbo 68
Zhengzhou 68
Changsha 67
Council Bluffs 62
Denver 60
San Francisco 58
Warsaw 58
Guangzhou 56
Orem 55
Stockholm 55
Fairfield 54
Rome 54
Nanchang 53
Brooklyn 50
Brussels 50
Montreal 50
Poplar 50
Bologna 49
Taizhou 49
Chicago 48
Redwood City 48
Falkenstein 47
Lancaster 47
Seoul 47
Atlanta 46
Phoenix 46
Chennai 44
Jiaxing 44
Taiyuan 44
Frankfurt am Main 42
Mexico City 42
Nuremberg 42
Amsterdam 40
Rio de Janeiro 39
Toronto 39
Johannesburg 37
Lomé 37
Washington 36
Belo Horizonte 35
Lappeenranta 34
San Jose 34
Haiphong 32
Jakarta 32
Cotonou 31
Vienna 28
Da Nang 27
Kent 26
Meda 26
Ankara 25
Fuzhou 25
Norwalk 25
Brasília 24
Boston 22
Brno 22
Baghdad 20
Lanzhou 20
Totale 21.761
Nome #
STUDIO PROSPETTICO MULTICENTRICO SULLA GESTIONE DEI DRENAGGI DOPO DUODENOCEFALOPANCREASECTOMIA UTILIZZANDO UN SISTEMA DI STRATIFICAZIONE DEL RISCHIO 675
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 576
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 374
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 260
Genomic characterization of hepatoid tumors: context matters 233
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 218
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 217
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 207
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 205
Gα15 in early onset of pancreatic ductal adenocarcinoma 205
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 204
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 203
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 196
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 195
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 195
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 192
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 192
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 189
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 187
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 186
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 186
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 186
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 182
Acute pancreatitis at the beginning of the 21st century: the state of the art. 180
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 180
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 179
Delaying surgery for patients with a previous SARS-CoV-2 infection 179
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 179
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 177
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 174
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 172
Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases 172
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 171
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 169
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 169
Results of a surveillance protocol for pancreatic BD-IPMNs 168
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 167
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 167
Efficacy of Endoscopic Minor Papilla Sphincterotomy for Symptomatic Santorinicele Endoscopic treatment of Santorinicele 165
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 165
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 164
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 164
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 163
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 162
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 161
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 161
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 160
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 159
Serous Cystic Neoplasms 158
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 158
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 158
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 158
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 158
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 158
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 157
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 157
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 156
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 155
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 155
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 154
An unforeseeable adverse event during ERCP 153
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 153
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 153
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 151
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 150
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 150
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 149
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 149
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 149
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 148
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 148
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 147
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 147
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 146
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 146
Surgical excision of developmental retrorectal cysts: results with long-term follow-up from a single institution. 145
The management of intraductal papillary mucinous neoplasms of the pancreas 145
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 144
Immune performance profile in pancreatic adenocarcinoma patients. 144
Cystic Neoplasm of the Pancreas 144
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 144
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 143
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 143
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 142
CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas 141
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 141
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 140
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 140
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or~Tail on Surgical and Oncological Outcome: A Propensity-Score~Matched Multicenter Study 140
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 139
Preoperative fecal elastase-1 (FE-1) adds value in predicting post-operative pancreatic fistula: not all soft pancreas share the same risk - A prospective analysis on 105 patients 139
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 139
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 139
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula 138
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study 138
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 138
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 137
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 136
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 136
Totale 17.588
Categoria #
all - tutte 132.911
article - articoli 124.884
book - libri 0
conference - conferenze 2.163
curatela - curatele 0
other - altro 2.017
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.847
Totale 265.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 293 117 49 78 48 171 104
2021/20221.828 184 448 51 139 59 34 33 127 98 51 139 465
2022/20234.811 291 521 401 765 398 1.324 114 307 473 53 97 67
2023/20242.660 88 217 261 277 281 417 169 221 47 102 429 151
2024/20256.738 356 335 248 1.027 359 203 420 345 996 497 664 1.288
2025/202614.645 1.417 1.390 1.636 3.575 5.367 1.260 0 0 0 0 0 0
Totale 37.852